Remer, E.; Badarni, M.; Hikri, E.; Dayan, A.; Levi, L.; Popovtzer, A.; Iraqi, M.; Porgador, A.; Joshua, B.-Z.; Bachar, G.;
et al. CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma. J. Clin. Med. 2020, 9, 3214.
https://doi.org/10.3390/jcm9103214
AMA Style
Remer E, Badarni M, Hikri E, Dayan A, Levi L, Popovtzer A, Iraqi M, Porgador A, Joshua B-Z, Bachar G,
et al. CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine. 2020; 9(10):3214.
https://doi.org/10.3390/jcm9103214
Chicago/Turabian Style
Remer, Eric, Mai Badarni, Elad Hikri, Avraham Dayan, Lirit Levi, Aron Popovtzer, Muhammed Iraqi, Angel Porgador, Ben-Zion Joshua, Gideon Bachar,
and et al. 2020. "CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma" Journal of Clinical Medicine 9, no. 10: 3214.
https://doi.org/10.3390/jcm9103214
APA Style
Remer, E., Badarni, M., Hikri, E., Dayan, A., Levi, L., Popovtzer, A., Iraqi, M., Porgador, A., Joshua, B.-Z., Bachar, G., Elkabets, M., Scaltriti, M., & Mizrachi, A.
(2020). CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine, 9(10), 3214.
https://doi.org/10.3390/jcm9103214
